Professional Documents
Culture Documents
Review
a r t i c l e
i n f o
Article history:
Available online 2 December 2011
Keywords:
Vitamin D
Preeclampsia
Preterm birth
Placenta
Decidua
VDR
CYP27B1
CYP24A1
a b s t r a c t
Impaired vitamin D status is common to many populations around the world. However, data suggest that
this is a particular problem for specic groups such as pregnant women. This has raised important questions concerning the physiological and clinical impact of low vitamin D levels during pregnancy, with
implications for classical skeletal functions of vitamin D, as well as its diverse non-classical actions.
The current review will discuss this with specic emphasis on the classical calciotropic effects of vitamin
D as well as the less well established immunological functions of vitamin D that may inuence pregnancy
outcome. The review also describes the pathways that are required for metabolism and function of vitamin D, and the various clinical complications that have been linked to impaired vitamin D status during
pregnancy.
2011 Elsevier Inc. All rights reserved.
Introduction
In the last 10 years there has been increased awareness of the
variability of vitamin D status in populations across the globe [1],
and a growing debate about the need for revised parameters for
vitamin D supplementation [2]. Recent reports by the Institute of
Medicine (IOM)1 have sought to clarify this by revising targets for
optimal vitamin D status, and recommended daily allowances for
safe intake of vitamin D [3]. However, it is important to recognize
that the IOM report focused specically on established calciotropic
and skeletal effects of vitamin D, and it remains unclear whether
similar guidelines will also apply to non-classical actions of vitamin D. Moreover, irrespective of the revised denitions for vitamin
D-sufciency and -insufciency, it is clear that sub-optimal
vitamin D remains a prevalent problem for 21st century society,
particularly for specic groups within the general population.
Prominent amongst these are pregnant women, where the functions of vitamin D appear to be diverse and complex. In the USA,
the 19881994 National Health and Nutrition Examination Survey
showed that 42% of African-American women of child-bearing age
were described as vitamin D-decient, with this being dened by
serum levels of the main circulating form of vitamin D (25-hydroxyvitamin D3, 25OHD3) less than 37.5 nM [4]. More recent studies of
vitamin D-deciency during pregnancy and lactation have underlined the magnitude of this problem [49]. For example, Bodnar
et al. showed that 83% of pregnant US black women and 47% of
pregnant white women were vitamin D-insufcient (<80 nM serum 25(OH)D3) at delivery, with similar values for neonates [5].
Studies of other populations in the USA [10,11], Canada [12,13],
the UK [14,15], Ireland [16], Europe [17], the Middle East and Asia
[1821], and Australia [15,22] have underlined the prevalence of
vitamin D-insufciency in pregnant women. In several of these reports it was observed that pregnant women with darker skin pigmentation were at even greater risk of low vitamin D status
when compared to pregnant women with lighter pigmented skin
[5,15,17,23]. The increasing evidence for vitamin D-insufciency
during pregnancy has prompted questions concerning the likely
physiological and clinical consequences of low serum levels of
25(OH)D3 for both the mother and fetus. A summary of the various
clinical problems that have been linked to maternal vitamin Dinsufciency during pregnancy is shown in Table 1. The aim of
the following review article will be to discuss our current understanding of the physiology of vitamin D during pregnancy, including both classical calciotropic actions and proposed non-classical
effects on inammation and immune function. The review will also
discuss the potential impact of low vitamin D status on pregnancy
outcomes, including adverse events such as preeclampsia and preterm birth.
0003-9861/$ - see front matter 2011 Elsevier Inc. All rights reserved.
doi:10.1016/j.abb.2011.11.018
38
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
Table 1
Vitamin D and pregnancy: effects of vitamin D status and/or intake on maternal and
fetal health.
Clinical problem
Maternal
Preeclampsia
Bacterial vaginosis
Gestational diabetes
Preterm birth
Fetal/neonatal
Small for gestational age
Fetal skeleton/bone
Neonatal bone mass
Childhood bone mass
Asthma
Type 1 diabetes
Multiple sclerosis
Autism
Maternalfetal HIV transfer
Reference
[194,197201,237,238]
[23,186,239]
[18,240242]
[184,243,244]
[245,246]
[247]
[216,248250]
[115,251]
[218,235,252255]
[230,231]
[232]
[256]
[190]
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
39
Fig. 1. Vitamin D metabolism and function during pregnancy. Schematic showing vitamin metabolism and key functional responses in maternal, placental and fetal systems.
Conversion of pro-hormone 25-hydroxyvitamin D3 (25(OH)D3) to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in maternal kidneys catalyzed by the enzyme 25-hydroxyvitamin
D-1a-hydroxylase (CYP27B1) supports elevated serum levels of 1,25(OH)2D3 during pregnancy. However, this does not readily cross the placenta. Expression of CYP27B1 and
the vitamin D receptor (VDR) in maternal and fetal components of the placenta supports extra-renal synthesis of 1,25(OH)2D3 during pregnancy. In the fetal trophoblast, this
is enhanced by gene silencing of the catabolic enzyme vitamin D 24-hydroxylase (CYP24A1). The putative function of enhanced placental synthesis of 1,25(OH)2D3 appears to
be immunomodulatory.
40
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
41
Recent studies using mouse models of pregnancy have emphasized the contribution of the placental vitamin D system to antiinammatory responses in this tissue. Pregnant mice challenged
in vivo with the immunogen lipopolysaccharide (LPS), a toll-like
receptor (TLR) ligand, showed increased placental expression of
mouse Cyp27b1 and Vdr [141]. This was consistent with previous
studies showing LPS induction of CYP27B1 and VDR in human
monocytes [142144] and indicates a potential immunomodulatory function for the vitamin D system in the placenta. The importance of the latter is endorsed by further studies in which male and
female mice heterozygous for Cyp27b1 or Vdr were mated to generate fetuses with complete ablation of these genes. Placentas from
knockout fetuses showed no expression of Cyp27b1 or Vdr in fetal
(trophoblastic) cells, and demonstrated a complete dysregulation
of inammatory responses following immune challenge with LPS
[141]. Conversely, in the presence of 25(OH)D3 or 1,25(OH)2D3
wild type placentas showed suppressed inammatory responses
to LPS challenge [141]. These data strongly suggest that a key function of vitamin D during pregnancy is to support normal immune
responses and thereby minimize the detrimental effects of inammation at the fetalmaternal interface (Fig. 1).
The rst putative model for vitamin D and implantation proposed that induction of CYP27B1 at the fetalmaternal interface
by inammatory cytokines provides a mechanism for enhancing local concentrations of 1,25(OH)2D3 [119]. This, in turn, could act to
promote key factors associated with successful implantation,
including calbindin-D9K, a key vitamin D target gene which is
important in the process of implantation [145]. Other vitamin D target genes associated with implantation include HOXA10 [145],
which is expressed in both the embryonic and the adult reproductive tracts, predominantly in the uterus [146]. HOXA10 is necessary
for embryo implantation and fertility, as well as hematopoietic
development, and HOXA10 knockout mice show defective decidualization [147,148]. Direct up-regulation of HOXA10 mRNA and
protein expression by 1,25(OH)2D3 is mediated via a functional
vitamin D response element (VDRE) in the 50 regulatory region of
the HOXA10 gene promoter [147]. Studies in vitro have shown that
vitamin D can also stimulate synthesis of hormones involved in
pregnancy such as estradiol, progesterone, and hCG [149,150].
Given the importance of these hormones in maintaining the regulation of uteroplacental blood ow, placental neovascularization,
maternal immunotolerance to the fetal allograft [151], this is likely
to be another important function for vitamin D at the fetal
maternal interface early in pregnancy.
Vitamin D and bacterial killing during pregnancy
Vitamin D also promotes innate immune responses, most notably by stimulating antimicrobial activity [152,153]. In cells such as
monocytes, expression of VDR and CYP27B1 is potently induced following TLR activation [154]. The resulting increase in local synthesis of 1,25(OH)2D3 is then able to trigger vitamin D responses via
interaction with endogenous VDR, leading to transcriptional regulation of monocyte target genes. These include the antimicrobial
proteins, cathelicidin [155], and b-defensin 2 [156], which enhance
intracellular killing of bacteria. Furthermore, vitamin D has also
been shown to act as a promoter of autophagy, a cytosolic process
that promotes the autophagosomal environment for pathogen
killing [157]. All of these antibacterial responses appear to be
dependent on intracrine production of 1,25(OH)2D3, with this
mechanism, in turn, being dependent on the availability of substrate 25(OH)D3 for CYP27B1. As 25(OH)D3 is the major circulating
form of vitamin D, the innate antimicrobial effects of vitamin D will
therefore be highly inuenced by patient vitamin D status. This was
conrmed by studies using monocytes cultured in the presence of
serum from vitamin D-sufcient donors which showed much
42
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
that vitamin D-induced innate immune responses within the placenta may play a role in combating MCTC of viral infections in general. Another link between vitamin D and spontaneous preterm
birth comes from proteomic studies showing increased levels of
DBP in human cervicalvaginal uid from women who experienced preterm labor [192]. The functional signicance of this is unclear but elevated levels of DBP during pregnancy may inuence
the function of vitamin D metabolites, notably 25(OH)D3.
Vitamin D deciency and preeclampsia
Preeclampsia is a common and serious complication of pregnancy affecting 310% of pregnancies worldwide [193]. It is a leading cause of maternal death and a major contributor to maternal
and perinatal morbidity. Preeclampsia is characterized by maternal
hypertension and proteinuria, which is associated with shallow
trophoblast invasion, impaired spiral artery remodeling, reduced
placental perfusion, oxidative stress, and increased inammatory
responses [194196]. Epidemiology suggests that there is a strong
link between vitamin D-insufciency and preeclampsia [197201].
Likewise, a cohort study of nulliparous pregnant women in Norway
showed a 27% reduction in risk of preeclampsia in women taking
vitamin D supplements relative to those who did not take supplements [194]. However, not all studies have demonstrated association between vitamin D status, gestational blood pressure and
subsequent preeclampsia [202]. Moreover, as yet, there have been
no blinded prospective trials to assess the possible protective effects of enhanced maternal vitamin D status with respect to
preeclampsia.
The precise mechanism by which vitamin D may inuence the
pathophysiology of pre-eclampsia is at present unclear, although
dysregulation of the vitamin D-activating enzyme CYP27B1 has
been described in trophoblastic cells from the placentas of preeclampsia mothers [203]. Maternal vitamin D status may inuence
preeclampsia through a variety of mechanisms including immunomodulatory, inammatory and angiogenic responses [204,205].
However, although the immunomodulatory properties of 25(OH)
D3 and 1,25(OH)2D3 have been proposed as a potential functional
link between vitamin D and preeclampsia [206], there have been
few if any functional studies to investigate this. Vitamin D may also
inuence preeclampsia through regulation of the renin-angiotensin
system (RAS) [196,207]. RAS is a regulatory cascade that plays a key
role in regulating blood pressure, electrolyte balance, and homeostasis, and inappropriate stimulation of the RAS has been associated
with hypertension, heart attack, and stroke. Therefore, tight regulation of renin synthesis and secretion is essential for effective regulation of blood pressure [208]. Renin cleaves angiotensinogen to
angiotensin-I (ANG I), which is then further cleaved by the enzyme
angiotensin-converting enzyme (ACE) to biologically active angiotensin-II (ANG II) [196]. Several recent studies have shown that serum levels of 1,25(OH)2D3 are inversely associated with blood
pressure or plasma renin activity [208213], with vitamin D acting
as a negative endocrine regulator of the RAS by direct transcriptional
suppression of renin gene expression [208]. Studies of the Vdr gene
knockout mouse have shown that VDR ablation activates the RAS
and leads to accumulation of ANG II and subsequent more severe renal damage in the renal brosis model [214].
There are two major types of angiotensin receptors: AT1 and
AT2. Activation of AT1 induces vasoconstriction, sympathetic activity, aldosterone release, and in doing so increases blood pressure,
whereas AT2 is involved in fetal tissue development [196].
Trophoblasts are rich in AT1 receptors and responsive to the ANG
II in the circulation. Multiple genes are regulated by AT1 receptor
signaling and include those encoding secreted proteins associated
with trophoblast invasion and angiogenesis [196]. RAS is believed
to play a critical role in regulation of placental blood ow and
43
fetoplacental circulation and appears to be a key factor in the initiation of preeclampsia [196]. Studies of transgenic rats expressing
the human angiotensinogen and renin genes demonstrated hypertension, proteinuria, and AT1-AA production during pregnancy
[207], underlining the critical role of renin in the development of
preeclampsia. In this way it is possible that increased renin activity
in pregnant women with low serum vitamin D may provide a
mechanism linking vitamin D and preeclampsia.
Vitamin D, fetal development, and programming
Vitamin D is involved in the regulation of cellular differentiation and apoptosis and can exert effects on fetal skeletal growth,
development of the immune system, and the brain. As fetal vitamin
D status is dependent on maternal levels of serum 25(OH)D3 [215],
it is clear that maternal vitamin D deciency during pregnancy
may affect growth and development in utero. This is illustrated
by recent studies of the link between maternal vitamin D status
and fetal skeletal growth detailed in Section 5 [114]. However,
maternal levels of vitamin D during pregnancy may also inuence
health of offspring during infancy, and in later life [62]. Children
born to mothers with vitamin D insufciency during pregnancy exhibit decits in bone mineral content at 9 years of age [115]. A prospective cohort study has also shown that maternal vitamin D
status affects bone growth in early childhood [216]. In this case
postnatal vitamin D supplementation to improve the vitamin D
status of children only partly ameliorated the differences in bone
growth induced by maternal vitamin D status during the fetal period. As a consequence the authors concluded that intrauterine deciency of vitamin D may have permanent consequences despite
improved postnatal nutrition. Adverse effects of maternal vitamin
D insufciency do not appear to be restricted to the classical skeletal effects of vitamin D. For example, several reports have linked
maternal vitamin D with altered fetal lung and/or immune development, and childhood asthma and respiratory tract infection
[201,217221].
In addition to effects on fetal development and childhood diseases outlined above, it has also been suggested that vitamin Dinsufciency in utero may have an impact on diseases in later life
in other words fetal programming of adult disease [222].
Gestational vitamin D insufciency has been linked to a range of
adult-onset disorders, such as, osteoporotic bone disease [223], altered brain development and adult mental health [224229], autoimmune disease [230232], asthma [218,233,234], and food
allergies [217,218,233,235]. Fetal programming requires a critical
window during fetal development in which the fetus is particularly
sensitive to changes that persist throughout the adulthood [222].
Therefore, low vitamin status during this critical window may have
a persisting impact on adult health outcomes [222]. At present the
hypothesized role of vitamin D in fetal programming is based primarily on epidemiology. However, in the coming years it is highly
likely that this will be claried by more functional studies that further explore the molecular cellular mechanisms of actions of vitamin D at the fetalmaternal interface during pregnancy. The
controlled, prospective studies with vitamin D supplementation
are also required in understanding the effects of vitamin D on fetal
development, and in shedding light on the role of vitamin D in prevention and treatment of these adverse consequences.
Vitamin D supplementation and pregnancy
An important recent development has been the expansion of
trials to assess the clinical benets of vitamin D supplementation
during pregnancy. However, given the nature of the clinical setting
in which supplementation takes place, this remains a controversial
44
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
issue with many safety considerations [236]. Clinical trials involving pregnant women in Turkey found that vitamin D supplementation during pregnancy could both decrease maternal bone
resorption and enhance bone mass in offspring during later life
[100]. Despite this, the supplementation regimen (400 IU/d of vitamin D3 and 1000 mg/d of calcium) was not sufcient to normalize
25(OH)D3 levels in the pregnant women, suggesting that higher
doses of 25(OH)D3 should be given to pregnant women [100]. This
important issue was addressed in a recent, double-blind, randomized clinical trial carried out to assess the safety and effectiveness
of vitamin D supplementation during pregnancy [59]. In this trial,
women with a singleton pregnancy received 400, 2000, or 4000 IU
of vitamin D3 per day from 12 to 16 weeks of gestation until delivery. The maternal and neonatal circulating concentrations of
25(OH)D3 were assessed along with possible side-effects. The primary aim of this study was to determine maternal and neonatal
serum 25(OH)D3 at delivery, and to also asses the relative efcacy
of the different supplementation regimens in achieving an optimal
serum 25(OH)D3 level of 80 nM. Women receiving 4000 IU/day
dose and their offspring were more likely to reach this optimal level at delivery, and this was achieved without any evidence of vitamin D toxicity, hypercalcemia and hypercalciuria, or an increase in
adverse events during pregnancy, regardless of race or ethnicity
[59]. This important study provides a platform for future trials to
safely investigate the wide-ranging health benets of vitamin D
supplementation during pregnancy.
Conclusions
There is now increasing evidence that vitamin D exerts diverse
effects during pregnancy. In its classical endocrine setting vitamin
D remains an important component of maternal calcium homeostasis. However, it is now clear that the actions of vitamin D are likely
to extend far beyond this, most notably effects on infection and
immunity during pregnancy. The current review highlights the potential array of maternal and fetal responses that may be inuenced
by vitamin D and, importantly, that may be dysregulated by vitamin D insufciency. Further studies are required to fully dene
the molecular and cellular mechanisms that underpin the proposed
functions of vitamin D during pregnancy. It will also be important
to develop new animal models to explore the metabolism and function of vitamin D in reproductive tissues. Finally another important
future development will be the expansion of clinical trials to assess
the clinical benets of vitamin D supplementation for both mother
and child.
References
[1] M.F. Holick, N. Engl. J. Med. 357 (2007) 266281.
[2] M.F. Holick, Ann. Epidemiol. 19 (2009) 7378.
[3] A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A.
Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J.
Rosen, S.A. Shapses, J. Clin. Endocrinol. Metab. 96 (2011) 5358.
[4] S. Nesby-ODell, K.S. Scanlon, M.E. Cogswell, C. Gillespie, B.W. Hollis, A.C.
Looker, C. Allen, C. Doughertly, E.W. Gunter, B.A. Bowman, Am. J. Clin. Nutr. 76
(2002) 187192.
[5] L.M. Bodnar, H.N. Simhan, R.W. Powers, M.P. Frank, E. Cooperstein, J.M.
Roberts, J. Nutr. 137 (2007) 447452.
[6] L.M. Bodnar, J.M. Catov, H.N. Simhan, M.F. Holick, R.W. Powers, J.M. Roberts, J.
Clin. Endocrinol. Metab. (2007).
[7] B.W. Hollis, C.L. Wagner, Am. J. Clin. Nutr. 84 (2006) 273.
[8] B.W. Hollis, C.L. Wagner, Cmaj 174 (2006) 12871290.
[9] B.W. Hollis, C.L. Wagner, Am. J. Clin. Nutr. 79 (2004) 717726.
[10] A.A. Ginde, A.F. Sullivan, J.M. Mansbach, C.A. Camargo Jr., Am. J. Obstet.
Gynecol. 202 (436) (2010) e431e438.
[11] D.D. Johnson, C.L. Wagner, T.C. Hulsey, R.B. McNeil, M. Ebeling, B.W. Hollis,
Am. J. Perinatol. 28 (2011) 712.
[12] L.A. Newhook, S. Sloka, M. Grant, E. Randell, C.S. Kovacs, L.K. Twells, Matern.
Child Nutr. 5 (2009) 186191.
[13] S. Sloka, J. Stokes, E. Randell, L.A. Newhook, J. Obstet. Gynaecol. Can. 31 (2009)
313321.
[14] V.A. Holmes, M.S. Barnes, H.D. Alexander, P. McFaul, J.M. Wallace, Br. J. Nutr.
102 (2009) 876881.
[15] L. Bowyer, C. Catling-Paull, T. Diamond, C. Homer, G. Davis, M.E. Craig, Clin.
Endocrinol. (Oxf) 70 (2009) 372377.
[16] M.N. ORiordan, M. Kiely, J.R. Higgins, K.D. Cashman, Ir. Med. J. 101 (240)
(2008) 242243.
[17] A.A. Madar, L.C. Stene, H.E. Meyer, Br. J. Nutr. 101 (2009) 10521058.
[18] H.J. Farrant, G.V. Krishnaveni, J.C. Hill, B.J. Boucher, D.J. Fisher, K. Noonan, C.
Osmond, S.R. Veena, C.H. Fall, Eur. J. Clin. Nutr. 63 (2009) 646652.
[19] A. Kazemi, F. Shari, N. Jafari, N. Mousavinasab, J. Womens Health (Larchmt)
18 (2009) 835839.
[20] M. Salek, M. Hashemipour, A. Aminorroaya, A. Gheiratmand, R. Kelishadi, P.M.
Ardestani, H. Nejadnik, M. Amini, B. Zolfaghari, Exp. Clin. Endocrinol. Diabetes
116 (2008) 352356.
[21] H. Narchi, J. Kochiyil, R. Zayed, W. Abdulrazzak, M. Agarwal, J. Obstet.
Gynaecol. 30 (2010) 137142.
[22] G.R. Teale, C.E. Cunningham, Aust. N. Z. J. Obstet. Gynaecol 50 (2010) 259261.
[23] L.M. Davis, S.C. Chang, J. Mancini, M.S. Nathanson, F.R. Witter, K.O. OBrien, J.
Pediatr. Adolesc. Gynecol. 23 (2010) 4552.
[24] M.R. Walters, D.L. Cuneo, A.P. Jamison, J. Steroid Biochem. 19 (1983) 913920.
[25] J. Merke, W. Kreusser, B. Bier, E. Ritz, Eur. J. Biochem. 130 (1983) 303308.
[26] M.R. Walters, Biochem. Biophys. Res. Commun. 103 (1981) 721726.
[27] P. Vigano, D. Lattuada, S. Mangioni, L. Ermellino, M. Vignali, E. Caporizzo, P.
Panina-Bordignon, M. Besozzi, A.M. Di Blasio, J. Mol. Endocrinol. 36 (2006)
415424.
[28] M. Blomberg Jensen, J.E. Nielsen, A. Jorgensen, E. Rajpert-De Meyts, D.M.
Kristensen, N. Jorgensen, N.E. Skakkebaek, A. Juul, H. Leffers, Hum. Reprod. 25
(2010) 13031311.
[29] D.K. Panda, D. Miao, M.L. Tremblay, J. Sirois, R. Farookhi, G.N. Hendy, D.
Goltzman, Proc. Natl. Acad. Sci. USA 98 (2001) 74987503.
[30] T. Yoshizawa, Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Y. Yoshihara, T.
Kawakami, K. Arioka, H. Sato, Y. Uchiyama, S. Masushige, A. Fukamizu, T.
Matsumoto, S. Kato, Nat. Genet. 16 (1997) 391396.
[31] L.E. Johnson, H.F. DeLuca, J. Nutr. 131 (2001) 17871791.
[32] B.P. Halloran, H.F. DeLuca, J. Nutr. 110 (1980) 15731580.
[33] S. Ozkan, S. Jindal, K. Greenseid, J. Shu, G. Zeitlian, C. Hickmon, L. Pal, Fertil.
Steril. 94 (2010) 13141319.
[34] K. Faserl, G. Golderer, L. Kremser, H. Lindner, B. Sarg, L. Wildt, B. Seeber, J. Clin.
Endocrinol. Metab. 96 (2011) E233241.
[35] S.A. Missmer, D.W. Cramer, Obstet. Gynecol. Clin. North. Am. 30 (2003) 119.
vii.
[36] N. Sidell, S.W. Han, S. Parthasarathy, Ann. N. Y. Acad. Sci. 955 (2002) 159173;
N. Sidell, S.W. Han, S. Parthasarathy, Ann. N. Y. Acad. Sci. 955 (2002) 159173.
discussion 199200, 396406.
[37] N. Santanam, A.A. Murphy, S. Parthasarathy, Ann. N. Y. Acad. Sci. 955 (2002)
183198;
N. Santanam, A.A. Murphy, S. Parthasarathy, Ann. N. Y. Acad. Sci. 955 (2002)
183198. discussion 119200, 396406.
[38] M. Speeckaert, G. Huang, J.R. Delanghe, Y.E. Taes, Clin. Chim. Acta 372 (2006)
3342.
[39] N. Yamamoto, V.R. Naraparaju, Cell. Immunol. 170 (1996) 161167.
[40] S.B. Mohamad, H. Nagasawa, Y. Uto, H. Hori, Anticancer Res. 22 (2002) 4297
4300.
[41] T. Ravnsborg, D.T. Olsen, A.H. Thysen, M. Christiansen, G. Houen, P. Hojrup,
Biochim. Biophys. Acta 1804 (2010) 909917.
[42] C.R. Borges, J.W. Jarvis, P.E. Oran, R.W. Nelson, J. Proteome Res. 7 (2008)
41434153.
[43] D. Zehnder, R. Bland, M.C. Williams, R.W. McNinch, A.J. Howie, P.M. Stewart,
M. Hewison, J. Clin. Endocrinol. Metab. 86 (2001) 888894.
[44] T.K. Gray, G.E. Lester, R.S. Lorenc, Science 204 (1979) 13111313.
[45] Y. Weisman, A. Harell, S. Edelstein, M. David, Z. Spirer, A. Golander, Nature
281 (1979) 317319.
[46] L. Diaz, I. Sanchez, E. Avila, A. Halhali, F. Vilchis, F. Larrea, J. Clin. Endocrinol.
Metab. 85 (2000) 25432549.
[47] K. Pospechova, V. Rozehnal, L. Stejskalova, R. Vrzal, N. Pospisilova, G.
Jamborova, K. May, W. Siegmund, Z. Dvorak, P. Nachtigal, V. Semecky, P.
Pavek, Mol. Cell. Endocrinol. 299 (2009) 178187.
[48] K.N. Evans, L. Nguyen, J. Chan, B.A. Innes, J.N. Bulmer, M.D. Kilby, M. Hewison,
Biol. Reprod. (2006).
[49] J.S. Shin, M.Y. Choi, M.S. Longtine, D.M. Nelson, Placenta 31 (2010) 1027
1034.
[50] K.N. Evans, J.N. Bulmer, M.D. Kilby, M. Hewison, J. Soc. Gynecol. Investig. 11
(2004) 263271.
[51] D. Zehnder, K.N. Evans, M.D. Kilby, J.N. Bulmer, B.A. Innes, P.M. Stewart, M.
Hewison, Am. J. Pathol. 161 (2002) 105114.
[52] E.E. Delvin, L. Gagnon, A. Arabian, W. Gibb, Mol. Cell. Endocrinol. 71 (1990)
177183.
[53] R. Ross, J. Florer, K. Halbert, L. McIntyre, Placenta 10 (1989) 553567.
[54] M.R. Haussler, C.A. Haussler, G.K. Whiteld, J.C. Hsieh, P.D. Thompson, T.K.
Barthel, L. Bartik, J.B. Egan, Y. Wu, J.L. Kubicek, C.L. Lowmiller, E.W. Moffet,
R.E. Forster, P.W. Jurutka, J. Steroid Biochem. Mol. Biol. 121 (2010) 8897.
[55] T. Sakaki, N. Kagawa, K. Yamamoto, K. Inouye, Front. Biosci. 10 (2005) 119
134.
[56] B. Novakovic, M. Sibson, H.K. Ng, U. Manuelpillai, V. Rakyan, T. Down, S. Beck,
T. Fournier, D. Evain-Brion, E. Dimitriadis, J.M. Craig, R. Morley, R. Saffery, J.
Biol. Chem. 284 (2009) 1483814848.
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
[57] R. Bouillon, F.A. Van Assche, H. Van Baelen, W. Heyns, P. De Moor, J. Clin.
Invest. 67 (1981) 589596.
[58] R. Kumar, W.R. Cohen, P. Silva, F.H. Epstein, J. Clin. Invest. 63 (1979) 342344.
[59] B.W. Hollis, D. Johnson, T.C. Hulsey, M. Ebeling, C.L. Wagner, J. Bone Miner.
Res. 26 (2011) 23412357.
[60] S.K. Paulson, K.K. Ford, C.B. Langman, Am. J. Physiol. 258 (1990) E158162.
[61] E.E. Delvin, M. Gilbert, M.C. Pere, J.M. Garel, J. Dev. Physiol. 10 (1988) 451
459.
[62] D.K. Dror, L.H. Allen, Nutr. Rev. 68 (2010) 465477.
[63] Y. Weisman, A. Vargas, G. Duckett, E. Reiter, A.W. Root, Endocrinology 103
(1978) 19921996.
[64] U. Lachenmaier-Currle, J. Harmeyer, J. Perinat. Med. 17 (1989) 127136.
[65] M. Turner, P.E. Barre, A. Benjamin, D. Goltzman, M. Gascon-Barre, Miner.
Electrolyte Metab. 14 (1988) 246252.
[66] F.R. Greer, B.W. Hollis, J.L. Napoli, J. Pediatr. 105 (1984) 6164.
[67] N. Cross, L. Hillman, S. Allen, G. Krause, Am. J. Clin. Nutr. (1995) 514523.
[68] T. Dahlman, H. Sjoberg, E. Bucht, Acta Obstet. Gynecol. Scand. 73 (1994) 393
398.
[69] K. Seki, N. Makimura, C. Mitsui, J. Hirata, I. Nagata, Am. J. Obstet. Gynecol. 164
(1991) 12481252.
[70] N. Rasmussen, A. Frolich, P. Hornnes, L. Hegedus, Br. J. Obstet. Gynaecol. 97
(1990) 857859.
[71] S. Gallacher, W. Fraser, O. Owens, F. Dryburgh, F. Logue, A. Jenkins, J. Kennedy,
I. Boyle, Eur. J. Endocrinol. 131 (1994) 369374.
[72] S. Baksi, A. Kenny, Biochem. Pharmacol. 27 (1978) 27652768.
[73] E. Spanos, K. Colston, I. Evans, L. Galante, S. Macauley, I. MacIntyre, Mol. Cell.
Endocrinol. 5 (1979) 163167.
[74] E. Spanos, D. Brown, J. Stevenson, I. MacIntyre, Biochim. Biophys. Acta 672
(1981) 715.
[75] R.M. Pitkin, Am. J. Obstet. Gynecol. 151 (1985) 99109.
[76] T. Shinki, Y. Ueno, H.F. DeLuca, T. Suda, Proc. Natl. Acad. Sci. USA 96 (1999)
82538258.
[77] Y. Zhong, H.J. Armbrecht, S. Christakos, J. Biol. Chem. 284 (2009) 11059
11069.
[78] L. Hillman, E. Slatopolsky, J. Haddad, J. Clin. Endocrinol. Metab. 47 (1978)
10731077.
[79] B. Lund, A. Selnes, Acta Endocrinol. (Copenh) 92 (1979) 330335.
[80] A. Fleischman, J. Rosen, J. Cole, C. Smith, H. DeLuca, J. Pediatr. 97 (1980) 640
642.
[81] K. Seki, K. Furuya, N. Makimura, C. Mitsui, J. Hirata, I. Nagata, J. Perinat. Med.
22 (1994) 189194.
[82] B. Hollis, W. Pittard, J. Clin. Endocrinol. Metab. 59 (1984) 652657.
[83] P. Wieland, J. Fischer, U. Trechsel, H. Roth, K. Vetter, H. Schneider, A. Huch,
Am. J. Physiol. 239 (1980) E385E390.
[84] J.G. Haddad Jr., V. Boisseau, L.V. Avioli, J. Lab. Clin. Med. 77 (1971) 908915.
[85] Y. Weisman, R. Sapir, A. Harell, S. Edelstein, Biochim. Biophys. Acta 428
(1976) 388395.
[86] S. Sunaga, N. Horiuchi, N. Takahashi, K. Okuyama, T. Suda, Biochem. Biophys.
Res. Commun. 90 (1979) 948955.
[87] R. Ross, A. Care, J. Robinson, D. Pickard, A. Weatherley, J. Endocrinol. 87 (1980)
17P18P.
[88] P. White, N. Cooke, Trends Endocrinol. Metab. 11 (2000) 320327.
[89] M.A. Haughton, R.S. Mason, Clin. Chem. 38 (1992) 17961801.
[90] D.D. Bikle, E. Gee, B. Halloran, J.G. Haddad, J. Clin. Invest. 74 (1984) 1966
1971.
[91] V.P. Walker, X. Zhang, I. Rastegar, P.T. Liu, B.W. Hollis, J.S. Adams, R.L. Modlin,
J. Clin. Endocrinol. Metab. 96 (2011) 18351843.
[92] A. Nykjaer, D. Dragun, D. Walther, H. Vorum, C. Jacobsen, J. Herz, F. Melsen,
E.I. Christensen, T.E. Willnow, Cell 96 (1999) 507515.
[93] M.J. Rowling, C.M. Kemmis, D.A. Taffany, J. Welsh, J. Nutr. 136 (2006) 2754
2759.
[94] C.M. Mendel, Endocr. Rev. 10 (1989) 232274.
[95] S. Lundgren, T. Carling, G. Hjalm, C. Juhlin, J. Rastad, U. Pihlgren, L. Rask, G.
Akerstrom, P. Hellman, J. Histochem. Cytochem. 45 (1997) 383392.
[96] N. Lambot, P. Lybaert, A. Boom, J. Delogne-Desnoeck, A.M. Vanbellinghen, G.
Graff, P. Lebrun, S. Meuris, Biol. Reprod. 75 (2006) 9097.
[97] R.H. Wasserman, C.A. Smith, M.E. Brindak, N. De Talamoni, C.S. Fullmer, J.T.
Penniston, R. Kumar, Gastroenterology 102 (1992) 886894.
[98] S. Miller, B. Halloran, H. DeLuca, W. Jee, Calcif. Tissue Int. 34 (1982)
245252.
[99] C. Kovac, Am. J. Clin. Nutr. 88 (Suppl) (2008) 520S528S.
[100] B. Haliloglu, E. Ilter, F.B. Aksungar, A. Celik, H. Coksuer, T. Gunduz, E. Yucel, U.
Ozekici, Eur. J. Obstet. Gynecol. Reprod. Biol. 158 (2011) 2427.
[101] C.S. Kovacs, Curr. Osteoporos. Rep. (2011).
[102] A.D. Care, J. Dev. Physiol. 15 (1991) 253257.
[103] A. Locatelli, L. Patane, A. Ghidini, E. Marinetti, A. Zagarella, J.C. Pezzullo, A.
Cappellini, J. Matern. Fetal Neonatal. Med. 11 (2002) 339344.
[104] C.S. Kovacs, H.M. Kronenberg, Endocr. Rev. 18 (1997) 832872.
[105] C.S. Kovacs, Am. J. Clin. Nutr. 88 (2008) 520S528S.
[106] C.S. Kovacs, M.L. Woodland, N.J. Fudge, J.K. Friel, Am. J. Physiol. Endocrinol.
Metab. 289 (2005) E133E144.
[107] N.J. Fudge, C.S. Kovacs, Endocrinology 151 (2010) 886895.
[108] M.S. Lima, F. Kallfelz, L. Krook, P.W. Nathanielsz, Calcif. Tissue Int. 52 (1993)
283290.
[109] R. Brommage, H.F. DeLuca, Am. J. Physiol. 246 (1984) F526529.
[110] B.P. Halloran, H.F. De Luca, Arch. Biochem. Biophys. 209 (1981) 714.
45
[111] S.C. Miller, B.P. Halloran, H.F. DeLuca, W.S. Jee, Calcif. Tissue Int. 35 (1983)
455460.
[112] D.E. Campbell, A.R. Fleischman, Clin. Perinatol. 15 (1988) 879890.
[113] B.L. Specker, Am. J. Clin. Nutr. 59 (1994) 484S490S;
B.L. Specker, Am. J. Clin. Nutr. 59 (1994) 484S490S. discussion 490S491S.
[114] P. Mahon, N. Harvey, S. Crozier, H. Inskip, S. Robinson, N. Arden, R.
Swaminathan, C. Cooper, K. Godfrey, J. Bone Miner. Res. 25 (2010) 1419.
[115] M.K. Javaid, S.R. Crozier, N.C. Harvey, C.R. Gale, E.M. Dennison, B.J. Boucher,
N.K. Arden, K.M. Godfrey, C. Cooper, Lancet 367 (2006) 3643.
[116] U. Lachenmaier-Currle, G. Breves, J. Harmeyer, Q. J. Exp. Physiol. 74 (1989)
875881.
[117] M.E. Bruns, D.E. Bruns, Ann. Clin. Lab. Sci. 13 (1983) 521530.
[118] M. Hewison, F. Burke, K.N. Evans, D.A. Lammas, D.M. Sansom, P. Liu, R.L.
Modlin, J.S. Adams, J. Steroid Biochem. Mol. Biol. 103 (2007) 316321.
[119] P. Vigano, S. Mangioni, F. Pompei, I. Chiodo, Placenta 24 (Suppl B) (2003) S56
S61.
[120] V.V. Snegovskikh, F. Schatz, F. Arcuri, P. Toti, U.A. Kayisli, W. Murk, L.
Guoyang, C.J. Lockwood, E.R. Norwitz, Reprod. Sci. 16 (2009) 767780.
[121] A. Moffett, C. Loke, Placenta 27 (Suppl A) (2006) S54S55.
[122] C. Rebut-Bonneton, J. Demignon, Gynecol. Obstet. Invest. 32 (1991) 134138.
[123] Y. Chambon, C. R. Seances Soc. Biol. Fil. 145 (1951) 955959.
[124] A. Halhali, G.M. Acker, M. Garabedian, J. Reprod. Fertil. 91 (1991) 5964.
[125] J.S. Adams, P. Liu, R. Chun, R.L. Modlin, M. Hewison, Ann. N. Y. Acad. Sci.
(2007).
[126] C. Mathieu, E. van Etten, B. Decallonne, A. Guilietti, C. Gysemans, R. Bouillon,
L. Overbergh, J. Steroid Biochem. Mol. Biol. 8990 (2004) 449452.
[127] M.T. Cantorna, Y. Zhu, M. Froicu, A. Wittke, Am. J. Clin. Nutr. 80 (2004)
1717S1720S.
[128] M.D. Grifn, N. Xing, R. Kumar, Annu. Rev. Nutr. 23 (2003) 117145.
[129] H.F. Deluca, M.T. Cantorna, FASEB J. 15 (2001) 25792585.
[130] M.J. Campbell, L. Adorini, Expert Opin. Ther. Targets 10 (2006) 735748.
[131] K. Townsend, K.N. Evans, M.J. Campbell, K.W. Colston, J.S. Adams, M.
Hewison, J. Steroid Biochem. Mol. Biol. 97 (2005) 103109.
[132] M. Hewison, D. Zehnder, R. Chakraverty, J.S. Adams, Mol. Cell. Endocrinol. 215
(2004) 3138.
[133] M. Kreutz, R. Andreesen, S.W. Krause, A. Szabo, E. Ritz, H. Reichel, Blood 82
(1993) 13001307.
[134] M. Hewison, L. Freeman, S.V. Hughes, K.N. Evans, R. Bland, A.G. Eliopoulos,
M.D. Kilby, P.A. Moss, R. Chakraverty, J. Immunol. 170 (2003) 53825390.
[135] A. Boonstra, F.J. Barrat, C. Crain, V.L. Heath, H.F. Savelkoul, A. OGarra, J.
Immunol. 167 (2001) 49744980.
[136] J.M. Lemire, D.C. Archer, L. Beck, H.L. Spiegelberg, J. Nutr. 125 (1995) 1704S
1708S.
[137] F.J. Barrat, D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, H.F. Savelkoul, R. de
Waal-Malefyt, R.L. Coffman, C.M. Hawrylowicz, A. OGarra, J. Exp. Med. 195
(2002) 603616.
[138] S. Joshi, L.C. Pantalena, X.K. Liu, S.L. Gaffen, H. Liu, C. Rohowsky-Kochan, K.
Ichiyama, A. Yoshimura, L. Steinman, S. Christakos, S. Youssef, Mol. Cell. Biol.
31 (2011) 36533669.
[139] K.N. Evans, L. Nguyen, J. Chan, B.A. Innes, J.N. Bulmer, M.D. Kilby, M. Hewison,
Biol. Reprod. 75 (2006) 816822.
[140] L. Diaz, N. Noyola-Martinez, D. Barrera, G. Hernandez, E. Avila, A. Halhali, F.
Larrea, J. Reprod. Immunol. 81 (2009) 1724.
[141] N.Q. Liu, A.T. Kaplan, V. Lagishetty, Y.B. Ouyang, Y. Ouyang, C.F. Simmons, O.
Equils, M. Hewison, J. Immunol. 186 (2011) 59685974.
[142] B. Cox, M. Kotlyar, A.I. Evangelou, V. Ignatchenko, A. Ignatchenko, K.
Whiteley, I. Jurisica, S.L. Adamson, J. Rossant, T. Kislinger, Mol. Syst. Biol. 5
(2009) 279.
[143] K. Stoffels, L. Overbergh, A. Giulietti, L. Verlinden, R. Bouillon, C. Mathieu, J.
Bone Miner. Res. 21 (2006) 3747.
[144] H. Reichel, H.P. Koefer, J.E. Bishop, A.W. Norman, J. Clin. Endocrinol. Metab.
64 (1987) 19.
[145] L.A. Salamonsen, G. Nie, J.K. Findlay, J. Reprod. Immunol. 53 (2002) 215225.
[146] H.S. Taylor, G.B. Vanden Heuvel, P. Igarashi, Biol. Reprod. 57 (1997) 1338
1345.
[147] H. Du, G.S. Daftary, S.I. Lalwani, H.S. Taylor, Mol. Endocrinol. 19 (2005) 2222
2233.
[148] H. Lim, L. Ma, W.G. Ma, R.L. Maas, S.K. Dey, Mol. Endocrinol. 13 (1999) 1005
1017.
[149] D. Barrera, E. Avila, G. Hernandez, A. Halhali, B. Biruete, F. Larrea, L. Diaz, J.
Steroid Biochem. Mol. Biol. 103 (2007) 529532.
[150] D. Barrera, E. Avila, G. Hernandez, I. Mendez, L. Gonzalez, A. Halhali, F. Larrea,
A. Morales, L. Diaz, Reprod. Biol. Endocrinol. 6 (2008) 3.
[151] E.D. Albrecht, G.J. Pepe, Endocr. Rev. 11 (1990) 124150.
[152] M. Hewison, Nat. Rev. Endocrinol. 7 (2011) 337345.
[153] J.S. Adams, M. Hewison, Nat. Clin. Pract. Endocrinol. Metab. 4 (2008) 8090.
[154] P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, S.R. Krutzik, M.T. Ochoa, J.
Schauber, K. Wu, C. Meinken, D.L. Kamen, M. Wagner, R. Bals, A. Steinmeyer,
U. Zugel, R.L. Gallo, D. Eisenberg, M. Hewison, B.W. Hollis, J.S. Adams, B.R.
Bloom, R.L. Modlin, Science 311 (2006) 17701773.
[155] M. Zanetti, J. Leukoc. Biol. 75 (2004) 3948.
[156] T.T. Wang, B. Dabbas, D. Laperriere, A.J. Bitton, H. Soualhine, L.E. TaveraMendoza, S. Dionne, M.J. Servant, A. Bitton, E.G. Seidman, S. Mader, M.A. Behr,
J.H. White, J. Biol. Chem. 285 (2010) 22272231.
[157] J.M. Yuk, D.M. Shin, H.M. Lee, C.S. Yang, H.S. Jin, K.K. Kim, Z.W. Lee, S.H. Lee,
J.M. Kim, E.K. Jo, Cell Host Microbe. 6 (2009) 231243.
46
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
[158] J.S. Adams, S. Ren, P.T. Liu, R.F. Chun, V. Lagishetty, A.F. Gombart, N.
Borregaard, R.L. Modlin, M. Hewison, J. Immunol. 182 (2009) 42894295.
[159] T.T. Wang, F.P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. TaveraMendoza, R. Lin, J.W. Hanrahan, S. Mader, J.H. White, J. Immunol. 173 (2004)
29092912.
[160] J. Schauber, R.A. Dorschner, A.B. Coda, A.S. Buchau, P.T. Liu, D. Kiken, Y.R.
Helfrich, S. Kang, H.Z. Elalieh, A. Steinmeyer, U. Zugel, D.D. Bikle, R.L. Modlin,
R.L. Gallo, J. Clin. Invest. 117 (2007) 803811.
[161] V. Lagishetty, A.V. Misharin, N.Q. Liu, T.S. Lisse, R.F. Chun, Y. Ouyang, S.M.
McLachlan, J.S. Adams, M. Hewison, Endocrinology 151 (2010) 24232432.
[162] N. Liu, L. Nguyen, R.F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H.F. Deluca,
J.S. Adams, M. Hewison, Endocrinology 149 (2008) 47994808.
[163] A.C. Zenclussen, A. Schumacher, M.L. Zenclussen, P. Wafula, H.D. Volk, Expert
Rev. Mol. Med. 9 (2007) 114.
[164] M. Kachkache, C. Rebut-Bonneton, J. Demignon, E. Cynober, M. Garabedian,
FEBS Lett. 333 (1993) 8388.
[165] G. Sacks, I. Sargent, C. Redman, Immunol. Today 21 (2000) 200201.
[166] G. Sacks, I. Sargent, C. Redman, Immunol. Today 20 (1999) 114118.
[167] I. Guleria, J.W. Pollard, Nat. Med. 6 (2000) 589593.
[168] G. Laskarin, U. Kammerer, D. Rukavina, A.W. Thomson, N. Fernandez, S.M.
Blois, Am. J. Reprod. Immunol. 58 (2007) 255267.
[169] N. Liu, A.T. Kaplan, J. Low, L. Nguyen, G.Y. Liu, O. Equils, M. Hewison, Biol.
Reprod. 80 (2009) 398406.
[170] C.R. Coid, H. Sandison, S. Slavin, D.G. Altman, Br. J. Exp. Pathol. 59 (1978) 292
297.
[171] R.L. Goldenberg, J.F. Culhane, J.D. Iams, R. Romero, Lancet 371 (2008) 7584.
[172] R.L. Goldenberg, J.F. Culhane, Clin. Perinatol. 30 (2003) 677700.
[173] R.L. Goldenberg, J.C. Hauth, W.W. Andrews, N. Engl. J. Med. 342 (2000) 1500
1507.
[174] J.N. Vergnes, M. Sixou, Am. J. Obstet. Gynecol. 196 (135) (2007) e131e137.
[175] D.J. Dudley, J. Reprod. Immunol. 36 (1997) 93109.
[176] R. Romero, J. Espinoza, L.F. Goncalves, J.P. Kusanovic, L. Friel, S. Hassan, Semin.
Reprod. Med. 25 (2007) 2139.
[177] R. Romero, J. Espinoza, L.F. Goncalves, J.P. Kusanovic, L.A. Friel, J.K. Nien,
Semin. Fetal Neonatal. Med. 11 (2006) 317326.
[178] R. Romero, O. Erez, J. Espinoza, J. Soc. Gynecol. Investig. 12 (2005) 463465.
[179] S.L. Hillier, S.S. Witkin, M.A. Krohn, D.H. Watts, N.B. Kiviat, D.A. Eschenbach,
Obstet. Gynecol. 81 (1993) 941948.
[180] M.G. Gravett, M.J. Novy, R.G. Rosenfeld, A.P. Reddy, T. Jacob, M. Turner, A.
McCormack, J.A. Lapidus, J. Hitti, D.A. Eschenbach, C.T. Roberts Jr., S.R.
Nagalla, Jama 292 (2004) 462469.
[181] S. El-Shazly, M. Makhseed, F. Azizieh, R. Raghupathy, Am. J. Reprod. Immunol.
52 (2004) 4552.
[182] V. Blank, E. Hirsch, J.R. Challis, R. Romero, S.J. Lye, Placenta 1 (2007) 12.
[183] R. Gomez, R. Romero, S.S. Edwin, C. David, Infect. Dis. Clin. North Am. 11
(1997) 135176.
[184] A. Dawodu, R. Nath, Pediat. Int. 53 (2011) 207210.
[185] A.M. Baker, S. Haeri, C.A. Camargo Jr., A.M. Stuebe, K.A. Boggess, Am. J.
Perinatol. 28 (2011) 667672.
[186] L.M. Bodnar, M.A. Krohn, H.N. Simhan, J. Nutr. 139 (2009) 11571161.
[187] L. Donati, A. Di Vico, M. Nucci, L. Quagliozzi, T. Spagnuolo, A. Labianca, M.
Bracaglia, F. Ianniello, A. Caruso, G. Paradisi, Arch. Gynecol. Obstet. 281
(2010) 589600.
[188] A.F. Gombart, N. Borregaard, H.P. Koefer, FASEB J. 19 (2005) 10671077.
[189] K.A. Rockett, R. Brookes, I. Udalova, V. Vidal, A.V. Hill, D. Kwiatkowski, Infect.
Immun. 66 (1998) 53145321.
[190] S. Mehta, D.J. Hunter, F.M. Mugusi, D. Spiegelman, K.P. Manji, E.L.
Giovannucci, E. Hertzmark, G.I. Msamanga, W.W. Fawzi, J. Infect. Dis. 200
(2009) 10221030.
[191] A.M. Al-Husaini, J. Perinatol. 29 (2009) 331336.
[192] L. Pereira, A.P. Reddy, T. Jacob, A. Thomas, K.A. Schneider, S. Dasari, J.A.
Lapidus, X. Lu, M. Rodland, C.T. Roberts Jr., M.G. Gravett, S.R. Nagalla, J.
Proteome Res. 6 (2007) 12691276.
[193] B. Sibai, G. Dekker, M. Kupferminc, Lancet 365 (2005) 785799.
[194] M. Haugen, A.L. Brantsaeter, L. Trogstad, J. Alexander, C. Roth, P. Magnus, H.M.
Meltzer, Epidemiology 20 (2009) 720726.
[195] L.C. Chappell, P.T. Seed, F.J. Kelly, A. Briley, B.J. Hunt, D.S. Charnock-Jones, A.
Mallet, L. Poston, Am. J. Obstet. Gynecol. 187 (2002) 777784.
[196] R.A. Irani, Y. Xia, Placenta 29 (2008) 763771.
[197] L.M. Bodnar, J.M. Catov, H.N. Simhan, M.F. Holick, R.W. Powers, J.M. Roberts, J.
Clin. Endocrinol. Metab. 92 (2007) 35173522.
[198] C.J. Robinson, M.C. Alanis, C.L. Wagner, B.W. Hollis, D.D. Johnson, Am. J.
Obstet. Gynecol. 203 (366) (2010) e361e366.
[199] A.M. Baker, S. Haeri, C.A. Camargo Jr., J.A. Espinola, A.M. Stuebe, J. Clin.
Endocrinol. Metab. 95 (2010) 51055109.
[200] C.J. Robinson, C.L. Wagner, B.W. Hollis, J.E. Baatz, D.D. Johnson, Am. J. Obstet.
Gynecol. 204 (556) (2011) e551e554.
[201] P.C. Woodham, J.E. Brittain, A.M. Baker, D.L. Long, S. Haeri, C.A. Camargo Jr.,
K.A. Boggess, A.M. Stuebe, Hypertension (2011).
[202] C.E. Powe, E.W. Seely, S. Rana, I. Bhan, J. Ecker, S.A. Karumanchi, R. Thadhani,
Hypertension 56 (2010) 758763.
[203] L. Diaz, C. Arranz, E. Avila, A. Halhali, F. Vilchis, F. Larrea, J. Clin. Endocrinol.
Metab. 87 (2002) 38763882.
[204] A. Lapillonne, Med. Hypotheses 74 (2010) 7175.
[205] B.D. LaMarca, J. Gilbert, J.P. Granger, Hypertension 51 (2008) 982988.
[206] E. Hypponen, Nutr. Rev. 63 (2005) 225232.
N.Q. Liu, M. Hewison / Archives of Biochemistry and Biophysics 523 (2012) 3747
[252] S.T. Weiss, A.A. Litonjua, Clin. Exp. Allergy 38 (2008) 385387.
[253] C.S. Algert, J.R. Bowen, S.L. Lain, H.D. Allen, J.M. Vivian-Taylor, C.L. Roberts,
Pediatr Allergy Immunol. 22 (2011) 836842.
[254] A. Chi, J. Wildre, R. McLoughlin, R.A. Wood, G.R. Bloomberg, M. Kattan, P.
Gergen, D.R. Gold, F. Witter, T. Chen, M. Holick, C. Visness, J. Gern, G.T.
OConnor, Clin. Exp. Allergy 41 (2011) 842850.
47
[255] C.A. Camargo Jr., T. Ingham, K. Wickens, R. Thadhani, K.M. Silvers, M.J. Epton,
G.I. Town, P.K. Pattemore, J.A. Espinola, J. Crane, Pediatrics 127 (2011) e180
e187.
[256] W.B. Grant, C.M. Soles, Dermatoendocrinol. 1 (2009) 223228.